journal article·2012-04-10

Design and Self‐Assembly of a Leucine‐Enkephalin Analogue in Different Nanostructures: Application of Nanovesicles

Pradyot Koley, Anindita Gayen, Michael G. B. Drew, Chaitali Mukhopadhyay, Animesh Pramanik

Small· Volume 8· Issue 7
Publisher page

Abstract

An opioid (leucine-enkephalin) conformational analogue forms diverse nanostructures such as vesicles, tubes, and organogels through self-assembly. The nanovesicles encapsulate the natural hydrophobic drug curcumin and allow the controlled release through cation-generated porogens in membrane mimetic solvent. Detailed facts of importance to specialist readers are published as ”Supporting Information”. Such documents are peer-reviewed, but not copy-edited or typeset. They are made available as submitted by the authors. Please note: The publisher is not responsible for the content or functionality of any supporting information supplied by the authors. Any queries (other than missing content) should be directed to the corresponding author for the article.
Source: openalex_inverted_index · Quality: baseline

Research context

OpenAlex topics: Supramolecular Self-Assembly in Materials · Lipid Membrane Structure and Behavior · Polydiacetylene-based materials and applications

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

References (46)

Show source-provided references
1. 10.1039/b605536m10.1039/b605536m ↗
2. 10.1039/c0cs90015j10.1039/c0cs90015j ↗
3. 10.1039/b915765b10.1039/b915765b ↗
4. 10.1002/adfm.20110146510.1002/adfm.201101465 ↗
5. 10.1039/b511336a10.1039/b511336a ↗
6. 10.1002/anie.20060338710.1002/anie.200603387 ↗
7. 10.1002/asia.20090027410.1002/asia.200900274 ↗
8. 10.1002/smll.20080096010.1002/smll.200800960 ↗
9. 10.2174/09298670677793504110.2174/092986706777935041 ↗
10. 10.1208/aapsj08010910.1208/aapsj080109 ↗
11. 10.1016/j.biocel.2008.06.01010.1016/j.biocel.2008.06.010 ↗
12. 10.1111/j.1471-4159.2007.05105.x10.1111/j.1471-4159.2007.05105.x ↗
13. 10.1186/1471-2202-11-110.1186/1471-2202-11-1 ↗
14. 10.1016/j.bbagen.2006.06.01210.1016/j.bbagen.2006.06.012 ↗
15. 10.1021/bm800683f10.1021/bm800683f ↗
16. 10.1021/la903772e10.1021/la903772e ↗
17. 10.1016/j.bcp.2009.09.00310.1016/j.bcp.2009.09.003 ↗
18. 10.1021/la101246a10.1021/la101246a ↗
19. Shah C. P. · Curr. Sci. · 2008 · 95 · 1426
20. 10.1016/j.biomaterials.2011.04.06910.1016/j.biomaterials.2011.04.069 ↗
21. Pede P. V. · Int. J. Pharmaceut. Sci. Rev. Res. · 2011 · 7 · 33
22. 10.1002/smll.20100151310.1002/smll.201001513 ↗
23. 10.1602/neurorx.2.1.4410.1602/neurorx.2.1.44 ↗
24. 10.1021/la704056d10.1021/la704056d ↗
25. 10.1016/j.tet.2005.03.10010.1016/j.tet.2005.03.100 ↗
26. 10.1016/j.tet.2007.07.07510.1016/j.tet.2007.07.075 ↗
27. 10.1016/S0040-4039(03)01642-310.1016/S0040-4039(03)01642-3 ↗
28. 10.1021/cb200103h10.1021/cb200103h ↗
29. 10.1002/anie.20080212310.1002/anie.200802123 ↗
30. 10.1021/la801605b10.1021/la801605b ↗
31. 10.1074/jbc.274.22.1559810.1074/jbc.274.22.15598 ↗
32. 10.1124/pr.57.1.110.1124/pr.57.1.1 ↗
33. 10.1021/ja908170s10.1021/ja908170s ↗
34. 10.1021/jo900222g10.1021/jo900222g ↗
35. 10.1016/j.tetlet.2005.09.15510.1016/j.tetlet.2005.09.155 ↗
36. 10.1021/jm900491310.1021/jm9004913 ↗
37. 10.1016/j.jmb.2003.12.08410.1016/j.jmb.2003.12.084 ↗
38. 10.1002/chem.20080001210.1002/chem.200800012 ↗
39. 10.1021/bm060871m10.1021/bm060871m ↗
40. 10.1021/ar900115310.1021/ar9001153 ↗
41. 10.1021/ja801618p10.1021/ja801618p ↗
42. 10.1021/la803424310.1021/la8034243 ↗
43. 10.1088/0957-4484/15/9/01510.1088/0957-4484/15/9/015 ↗
44. 10.1039/b701665d10.1039/b701665d ↗
45. 10.1016/j.jconrel.2010.05.02610.1016/j.jconrel.2010.05.026 ↗
46. 10.1016/j.drudis.2008.09.00510.1016/j.drudis.2008.09.005 ↗